Cassava Sciences, Inc. (SAVA)
After hours:
| Previous close | 19.85 |
| Open | 19.95 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1200 |
| Day's range | 19.74 - 21.32 |
| 52-week range | 13.84 - 124.79 |
| Volume | |
| Avg. volume | 1,486,961 |
| Market cap | 817.143M |
| Beta (5Y monthly) | 1.03 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.56 |
| Earnings date | 19 Apr 2022 - 25 Apr 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 13 Dec 2012 |
| 1y target est | 72.50 |
- Simply Wall St.
We're Not Very Worried About Cassava Sciences' (NASDAQ:SAVA) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
- Reuters
Exclusive-Cassava Sciences faces U.S. criminal probe tied to Alzheimer's drug, sources say
The U.S. Justice Department has opened a criminal investigation into Cassava Sciences Inc involving whether the biotech company manipulated research results for its experimental Alzheimer's drug, two people familiar with the inquiry said. The Justice Department personnel conducting the investigation into Austin, Texas-based Cassava specialize in examining whether companies or individuals have misled or defrauded investors, government agencies or consumers, according to the sources, who spoke on condition of anonymity. As in any Justice Department investigation, this one could lead to criminal charges or be closed without any charges being brought.
- Zacks
Cassava Sciences, Inc. (SAVA) Gains As Market Dips: What You Should Know
In the latest trading session, Cassava Sciences, Inc. (SAVA) closed at $21.72, marking a +0.14% move from the previous day.
